AbbVie’s Skyrizi Bests Stelara Head-To-Head In Crohn’s

 
• By Joseph Haas
Head to head
AbbVie's Skyrizi prevailed in a head-to-head trial versus Stelara • Source: Shutterstock

More from Clinical Trials

More from R&D